Newomics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
804 Heinz Ave Ste 150, Berkeley, Califor...Phone Number
(510) 833-2811Website
www.newomics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Newomics
Newomics specializes in high-performance devices for liquid chromatography-mass spectrometry (LC-MS), offering innovative solutions such as the UniESI system and MEA chip. Their products are designed for applications in clinical mass spectrometry, metabolomics, and proteomics, providing enhanced sensitivity and throughput. The company targets clients in clinical diagnostics, biomarker discovery, drug development, and environmental monitoring. Newomics is committed to advancing multiomics technologies with plug-and-play compatibility and robust performance.Explore more
Newomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Newomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Newomics
Click to see if Newomics had a recent Job posting/layoffs
Check out if Newomics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Newomics recently announced quarterly report
Check if Newomics has recently received funding, and reach out quickly before it becomes old news!
Newomics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Newomics has new funding data
Product Launch: Get notified when Newomics launches new products
Recommended Actions
Find VP level buyers at Newomics
Find 2 more new buyers
Compare Similar Companies to Newomics
Compare insights from companies similar to Newomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Newomics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Newomics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Newomics.
Newomics financials insights
Gather financial insights about Newomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$3.9M
2020
Debt
$150K
Series B
$7.9M
Newomics Tech Stack
A closer look at the technologies used by Newomics
Most Recent Scoops
Person-Based
Facilities Relocation / Expansion
Newomics is planning to move its offices in December 2022. The move will impact employees at their existing office located at 804 Heinz Ave, Suite #150, Berkeley, CA.
Funding
Product Launch
Product Launch, Research & Development, Clinical Systems
Funding
Newomics News & Media
CORRECTING and REPLACING Newomics Announces Collaborations on High-throughput Bioanalysis
BERKELEY, Calif.--(BUSINESS WIRE)--Please replace the release dated March 2, 2022 with the following corrected version due to multiple revisions. The updated release reads: NEWOMICS ANNOUNCES COLLABORATIONS ON HIGH-THROUGHPUT BIOANALYSIS Newomics Inc., a biotechnology company commercializing mass spectrometry solutions for molecular detection, today announced collaborations with Bruker Corporation, a company with differentiated high-value life science research and diagnostics solutions, on a noNewomics and Bruker Announce Collaborations on High-throughput Bioanalysis
BERKELEY, Calif.--(BUSINESS WIRE)--Newomics Inc., a biotechnology company commercializing mass spectrometry solutions for molecular detection, and Bruker Corporation, with differentiated high-value life science research and diagnostics solutions, today announced collaborations on a novel LC-MS platform for drug discovery in the Pharma/Biopharma industry as well as research institutions. The two companies agreed on co-marketing Newomics’s Microflow-nanospray Electrospray Ionization (MnESI) produNewomics Announces Sales Team and New Kits
BERKELEY, Calif.--(BUSINESS WIRE)--Newomics Inc., a biotechnology company developing and commercializing mass spectrometry solutions, today announced that it has established a North America Sales Team, and it is launching a new product to enhance the existing mass spectrometry workflows. Newomics continues its dedication to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. The MnESI platform (M3 multinozzle emitter + MnESI sourNewomics Closes $7.9 Million Series B Financing to Accelerate Growth
The proceeds will be used to launch new products, grow the sales and marketing team, enhance customer support, and expand the collaborations with prominent mass spectrometer vendors.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Newomics
Sign Up For FreeTo access detailed company insights
Newomics specializes in high-performance devices for liquid chromatography-mass spectrometry (LC-MS), offering innovative solutions such as the UniESI system and MEA chip. Their products are designed for applications in clinical mass spectrometry, metabolomics, and proteomics, providing enhanced sensitivity and throughput. The company targets clien... Read More
